DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @thejadedtrader | 4 |
| @1MinuteStock | 4 |
| @confcalltran | 3 |
| @Tickeron | 3 |
| @dhovekamp42 | 3 |
Recent Tweets for FATE
 |
@thejadedtrader RT @jfais20: $FATE - Fate Therapeutics: Pioneer In iPSC Space Continues To Make Progress https://t.co/eWRMyX5t62 1:09pm |
 |
@jfais20 $FATE - Fate Therapeutics: Pioneer In iPSC Space Continues To Make Progress https://t.co/eWRMyX5t62 10:09am |
 |
@AmericanBanking Fate Therapeutics $FATE Price Target Cut to $28.00 https://t.co/4e8mT793zj #stocks 9:09am |
 |
@stockhoot $FATE Piper Jaffray Maintains to Overweight : PT $28.00 https://t.co/T1ylWQF226 7:09am |
 |
@SeekingAlpha $FATE - Fate Therapeutics: Pioneer In iPSC Space Continues To Make Progress https://t.co/IdH0UlTNkn 6:09am |
 |
@ConsumerFeed Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/5uSsiu1CFj September 15th 2019, 1:09pm |
 |
@macondailynews Fate Therapeutics $FATE Stock Price Down 5.1% https://t.co/2JMivP1YXT September 14th 2019, 6:09pm |
 |
@ZolmaxNews Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/o1pmfWBGD9 September 14th 2019, 12:09am |
|
@ZolmaxNews Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/PrIyozbmV4 September 13th 2019, 11:09pm |
 |
@dailypoliticaln Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/kRtqojSIQ1 September 13th 2019, 11:09pm |
 |
@WatchlistN Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/eekcufQlDV September 13th 2019, 11:09pm |
 |
@Tickeron $FATE in Uptrend: 50-day Moving Average moved above 200-day Moving Average on October 10, 2017. View odds for this… https://t.co/z5rlwQrg9p September 13th 2019, 10:09pm |
 |
@ECMUS RT @1stOncology: #FateTherapeutics Announces Pricing of Public Offering of Common Stock $FATE https://t.co/DA0FMZrvgs September 13th 2019, 1:09pm |
 |
@1stOncology #FateTherapeutics Announces Pricing of Public Offering of Common Stock $FATE https://t.co/DA0FMZrvgs September 13th 2019, 11:09am |
|
@1stOncology #FateTherapeutics Announces Proposed Public Offering of Common Stock $FATE https://t.co/zcBSzYndXR September 13th 2019, 11:09am |
 |
@marketexclusive $FATE FATE THERAPEUTICS, INC. (NASDAQ:FATE) Files An 8-K Entry into a Material Definitive Agreement https://t.co/PEH0r2wRy5 September 13th 2019, 10:09am |
 |
@1MinuteStock We calculated 21-day Expected Return of $FATE for you: -2.47% https://t.co/QBxddcbBNG September 13th 2019, 7:09am |
|
@1MinuteStock Wondering about risks of $FATE? The 21-day volatility is 20.16% https://t.co/qWY2XKvF0U September 13th 2019, 6:09am |
 |
@confcalltran Fate Therapeutics Announces Proposed Public Offering Of Common Stock https://t.co/Ljdr8UQBJp $FATE September 13th 2019, 6:09am |
|
@confcalltran FATE THERAPEUTICS INC just filed a prospectus, suggesting it plans to soon issue some securitie https://t.co/i72PlBlSox $FATE September 13th 2019, 6:09am |
 |
@registrarjourn Fate Therapeutics $FATE Trading Down 5.1% https://t.co/ViOK44kfrR September 13th 2019, 12:09am |
 |
@EnterpriseLeade Fate Therapeutics $FATE Trading Down 5.1% https://t.co/a0qMPyNKq9 September 13th 2019, 12:09am |
 |
@dispatchtribune Fate Therapeutics $FATE Stock Price Down 5.1% https://t.co/78iUqHpiwK September 12th 2019, 11:09pm |
|
@Tickeron $FATE's 10-day Moving Average broke below its 50-day Moving Average on August 12, 2019. View odds for this and othe… https://t.co/kcsrIsGsXv September 12th 2019, 7:09pm |
 |
@FlynancialA $FATE . . . https://t.co/Z3Na7qFxfj September 12th 2019, 6:09pm |
 |
@BlindSpotFunds @Dadbod4evah Its smart of $FATE to sell shrs now. In biotech, when the $ is available, take it ! To many CEOs, ov… https://t.co/H9kqyk0dtT September 12th 2019, 9:09am |
 |
@ToothFrank $FATE prices offering. 8.6M shares priced at $17.50/share September 12th 2019, 8:09am |
 |
@Briefingcom $FATE: Fate Therapeutics prices 8.6 mln shares of common stock at $17.50 per share https://t.co/hNNIhtDTov September 12th 2019, 8:09am |
 |
@LanderJesse RT @BioStocks: $FATE prices offering. 8.6M shares priced at $17.50/share. September 12th 2019, 7:09am |
 |
@BioStocks $FATE prices offering. 8.6M shares priced at $17.50/share. September 12th 2019, 6:09am |
 |
@StockNewsWires $FATE: Fate Therapeutics prices stock offering at $17.50: https://t.co/pa1BaiHJfi September 12th 2019, 6:09am |
 |
@MarketCurrents $FATE - Fate Therapeutics prices stock offering at $17.50 https://t.co/j4SC0bZhFW September 12th 2019, 5:09am |
 |
@dhovekamp42 RT @_B_I_O_T_E_C_H_: $Fate Therapeutics Prices Underwritten Public Offering Of 8.6 Mln Shares At $17.50/Shr September 12th 2019, 4:09am |
 |
@_B_I_O_T_E_C_H_ $Fate Therapeutics Prices Underwritten Public Offering Of 8.6 Mln Shares At $17.50/Shr September 12th 2019, 3:09am |
 |
@2ndry_filings $FATE - Overnight - No Shares Disclosed - Jefferies, Citi • Commentary on if you should indicate for $FATE or if yo… https://t.co/WLwU5efXlI September 12th 2019, 1:09am |
 |
@StockTexts $FATE Fate Therapeutics Announces Pricing of Public Offering of Common Stock Nasdaq:FATE https://t.co/1onnEL0p3A September 12th 2019, 1:09am |
 |
@tstamm7002 $FATE offering ahead of some key clinical disclosures this fall. timing is suspect September 11th 2019, 10:09pm |
|
@Tickeron $FATE's Aroon indicator reaches into Uptrend on September 9, 2019. View odds for this and other indicators:… https://t.co/oqs3Qjy9Y8 September 11th 2019, 7:09pm |
|
@thejadedtrader $EDIT and $FATE differentiates from MD Anderson by using iPSC vs chord blood derived NK cells. With the correct ed… https://t.co/V3yxtc0kM0 September 11th 2019, 6:09pm |
|
@thejadedtrader CAR-NK vs CAR-T $EDIT $FATE https://t.co/hT5jpWE2vo September 11th 2019, 6:09pm |
|
@thejadedtrader $FATE https://t.co/UcjHk2Lani September 11th 2019, 6:09pm |
|
@1MinuteStock Not sure what to do with $FATE? Explore our #fundamental pros and cons. https://t.co/jHpjDms2ik September 11th 2019, 6:09pm |
|
@Briefingcom $FATE: Fate Therapeutics commences public offering of common stock; amount of shares not disclosed https://t.co/iXTHLVYkKB September 11th 2019, 6:09pm |
|
@dhovekamp42 RT @TheTradeXchange: $FATE: Announces Proposed Public Offering of Common Stock.. Jefferies and Citi bookmanagers September 11th 2019, 5:09pm |
|
@dhovekamp42 RT @Stock_News_Now: $FATE: New SEC Filing for FATE: Form 424B5 (No. 0001193125-19-242947): https://t.co/fL8ENHd99O September 11th 2019, 5:09pm |
|
@1MinuteStock Do you know that #Book Value for $FATE is $1.95 https://t.co/hUBxlkxpcj September 11th 2019, 5:09pm |
 |
@gulfgator33 $FATE Ha, can't say I'm surprised, hopefully there will be strong demand. Such is the world of bio-tech September 11th 2019, 4:09pm |
 |
@Stock_News_Now $FATE: New SEC Filing for FATE: Form 424B5 (No. 0001193125-19-242947): https://t.co/fL8ENHd99O September 11th 2019, 4:09pm |
|
@confcalltran FATE THERAPEUTICS INC just filed a prospectus, suggesting it plans to soon issue some securitie https://t.co/rOgib7lVif $FATE September 11th 2019, 4:09pm |
 |
@soloalam1 RT @MarketCurrents: $FATE - Fate Therapeutics launches stock offering https://t.co/O3pvj6PEWw September 11th 2019, 4:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.